Back
Keros Therapeutics Stock Price Chart
7 Best Stocks for the Next 30 Days Free from Zacks Investment Research
Check the box to download this report FREE.
Sell
22
KROS
Keros Therapeutics
Last Price:
31.83
Seasonality Move:
66.67%
7 Day Trial
ALL ACCESS PASS
$
7
Free ChatGPT Investor Guide: 5 Stocks to Buy ASAP
Access the report now.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.
Keros Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.44 | Sell |
| 20-day SMA: | 34.47 | Sell |
| 50-day SMA: | 36.51 | Sell |
| 200-day SMA: | 44.14 | Sell |
| 8-day EMA: | 32.71 | Sell |
| 20-day EMA: | 33.97 | Sell |
| 50-day EMA: | 36.17 | Sell |
| 200-day EMA: | 41.36 | Sell |
Keros Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.26 | Sell |
| Relative Strength Index (14 RSI): | 34.54 | Sell |
| Chaikin Money Flow: | -143172 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.05 - 36.31) | Sell |
| Bollinger Bands (100): | (34.98 - 45.18) | Sell |
Keros Therapeutics Technical Analysis
| Sep 18 | Sep 19 | Sep 20 | Sep 21 | Sep 22 | Sep 25 | Sep 26 | Sep 27 | Sep 28 | Sep 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Keros Therapeutics Stock
Is Keros Therapeutics Stock a Buy?
- Keros Therapeutics share price is 31.83 while KROS 8-day simple moving average is 32.44, which is a Sell signal.
- The stock price of KROS is 31.83 while Keros Therapeutics 20-day SMA is 34.47, which makes it a Sell.
- Keros Therapeutics 50-day simple moving average is 36.51 while KROS share price is 31.83, making it a Sell technically.
- KROS stock price is 31.83 and Keros Therapeutics 200-day simple moving average is 44.14, creating a Sell signal.
KROS Technical Analysis vs Fundamental Analysis
Sell
22
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy or a Sell?
-
Keros Therapeutics stock is rated a Sell
The current Keros Therapeutics [KROS] share price is $31.83. The Score for KROS is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
Keros Therapeutics Stock Info
Market Cap:
944.18M
Price in USD:
31.83
Share Volume:
151.37K
Keros Therapeutics 52-Week Range
52-Week High:
59.96
52-Week Low:
31.17
Sell
22
Keros Therapeutics (KROS)
is a Sell
Keros Therapeutics Share Price Forecast
-
What is the Keros Therapeutics stock price today?
The Keros Therapeutics stock price is 31.83 USD today. -
Will KROS stock go up or go down?
Keros Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Keros Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Keros Therapeutics is overvalued.
Is Keros Therapeutics Stock a Buy?
- Keros Therapeutics share price is 31.83 while KROS 8-day exponential moving average is 32.71, which is a Sell signal.
- The stock price of KROS is 31.83 while Keros Therapeutics 20-day EMA is 33.97, which makes it a Sell.
- Keros Therapeutics 50-day exponential moving average is 36.17 while KROS share price is 31.83, making it a Sell technically.
- KROS stock price is 31.83 and Keros Therapeutics 200-day simple moving average is 41.36, creating a Sell signal.
Fundamental Analysis of Keros Therapeutics
Is Keros Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $0.02 per share.
Technical Analysis of Keros Therapeutics
Should I short Keros Therapeutics stock?
- KROS Moving Average Covergence Divergence (MACD) indicator is -1.26, suggesting Keros Therapeutics is a Sell
- Keros Therapeutics Relative Strength Index (RSI) is 34.54, which suggest Keros Therapeutics is oversold
- The Bollinger Bands (25) for Keros Therapeutics is (33.05 - 36.31), which suggest Keros Therapeutics is a Sell
- The Bollinger Bands (100) for Keros Therapeutics is (34.98 - 45.18), which suggest Keros Therapeutics is a Sell
* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.